Characterisation of a novel p53 down-regulated promoter in intron 3 of the human MDM2 oncogene

被引:12
|
作者
Liang, HL [1 ]
Lunec, J [1 ]
机构
[1] Newcastle Univ, Sch Med, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
MDM2; p53; promoter;
D O I
10.1016/j.gene.2005.07.018
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The MDM2 oncogene exhibits a complex expression pattern partly due to the usage of multiple promoters. Two MDM2 promoters (PI and P2) have been identified. P1 is located upstream of exon 1 and is modulated by PTEN. P2 sits in intron 1 and is activated by p53. Here we report the discovery of a third promoter (designated P3) in intron 3 of this gene, which contains a TATA-box element and p53DNA-binding sequences. DNA-protein binding assays indicated that p53 bound to this region specifically. This region also demonstrated promoter activity in a reporter gene system, which was down-regulated by p53. Furthermore, experiments combining P2 and P3 in the same reporter construct indicated that P3 had a suppressive effect on P2 at high levels of p53. These results suggest that one of the P3 functions is to dampen the expression of MDM2 at high levels of p53, adding an additional element to the feedback loop between p53 and MDM2. (c) 2005 Elsevier B.V All rights reserved.
引用
收藏
页码:112 / 118
页数:7
相关论文
共 50 条
  • [21] Subcellular distribution of p53 and p73 are differentially regulated by MDM2
    Gu, JJ
    Nie, LH
    Kawai, H
    Yuan, ZM
    CANCER RESEARCH, 2001, 61 (18) : 6703 - 6707
  • [22] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Manuela Argentini
    Nadia Barboule
    Bohdan Wasylyk
    Oncogene, 2001, 20 : 1267 - 1275
  • [23] Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma
    Segers, K
    Backhovens, H
    Kumar-Singh, S
    DeVoecht, J
    Ramael, M
    Van Broeckhoven, C
    VanMarck, E
    VIRCHOWS ARCHIV, 1995, 427 (04) : 431 - 436
  • [24] P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA
    Minguzzi, M.
    Giovannini, C.
    Gramantieri, L.
    Chieco, P.
    Marcu, K. B.
    Mastroleo, C.
    Piscaglia, F.
    Bolondi, L.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S24 - S25
  • [25] MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma
    Zhou, X.
    Rock, J.
    McNally, M. E.
    Bloomston, M.
    Zhao, W.
    Lozanski, G.
    Frankel, W. L.
    MODERN PATHOLOGY, 2012, 25 : 450A - 450A
  • [26] The contribution of the acidic domain of MDM2 to p53 and MDM2 stability
    Argentini, M
    Barboule, N
    Wasylyk, B
    ONCOGENE, 2001, 20 (11) : 1267 - 1275
  • [27] P53 IS REGULATED BY NOTCH3 SIGNALLING VIA MDM2 IN HEPATOCELLULAR CARCINOMA
    Minguzzi, Manuela
    Giovannini, Catia
    Gramantieri, Laura
    Chieco, Pasquale
    Marcu, Kenneth B.
    Mastroleo, Chiara
    Bolondi, Luigi
    HEPATOLOGY, 2010, 52 (04) : 606A - 606A
  • [28] Ribosomal protein S7 as a novel modulator of p53–MDM2 interaction: binding to MDM2, stabilization of p53 protein, and activation of p53 function
    D Chen
    Z Zhang
    M Li
    W Wang
    Y Li
    E R Rayburn
    D L Hill
    H Wang
    R Zhang
    Oncogene, 2007, 26 : 5029 - 5037
  • [29] MDM2 AND P53 - A QUESTION OF BALANCE
    MELTZER, PS
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1265 - 1266
  • [30] p53 and Mdm2: An auld alliance
    Vigneron, Arnaud
    Vousden, Karen H.
    CELL CYCLE, 2010, 9 (05) : 865 - 866